MannKind Announces Completion of Cohort 1 and Opens Enrollment for Cohort 2 of Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients https://t.co/9DBDqDBYqL
@GingerVieira I am extremely fortunate..I am T1d and pay $0 for insulin, and any diabetic supplies- test strips, sensors, Cgm, pen needles etc. Down side is I will probably never retire.. 😳😄
David.....Buffalos newest #afrezza user is going to kick ass.
Has dexcom, hates pumps, wanted a faster insulin. Gets and understands the pyramid shift
Better numbers ✔️
Not connected to a pump ✔️
Less lows✔️
Not waiting hrs for sugars to come down ✔️
#inalmannitrust
NEW VIDEO
Please 👀 watch, share and show to all diabetics.
@BreannaFuss did an excellent job
If your wearing a pump there’s a much better solution that’s faster and way less cumbersome.
#afrezza#inalmannitrust
https://t.co/J5RWIjdzoY